Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
Author(s) -
Yuchen Chen,
Dong Yang,
Biao Cheng,
Jian Chen,
Anlin Peng,
Chen Yang,
Chong Liu,
Mingrui Xiong,
Aiping Deng,
Yu Zhang,
Ling Zheng,
Kun Huang
Publication year - 2020
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc20-0660
Subject(s) - medicine , diabetes mellitus , odds ratio , retrospective cohort study , type 2 diabetes , logistic regression , covid-19 , comorbidity , blood pressure , endocrinology , disease , infectious disease (medical specialty)
Diabetes is one of the most distinct comorbidities of COVID-19. Here, we describe the clinical characteristics of and outcomes in patients with diabetes in whom COVID-19 was confirmed or clinically diagnosed (with typical features on lung imaging and symptoms) and their association with glucose-lowering or blood pressure-lowering medications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom